BamSEC and AlphaSense Join Forces
Learn More

BioCryst Pharmaceuticals Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: BCRX    
Share price (7/2/26): $9.84    
Market cap (7/2/26): $2.501 billion
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 122 pages Agreement and Plan of Merger Among BioCryst Pharmaceuticals, Inc., Axel Merger Sub, Inc. and Astria Therapeutics, Inc. Dated as of October 14, 2025
12/34/56
EX-2.1
from 8-K 286 pages Stock Purchase Agreement Dated as of June 27, 2025 by and Among BioCryst Pharmaceuticals, Inc., as the Seller, BioCryst Ireland Limited, as the Company, and Neopharmed Gentili S.P.A., as the Purchaser
12/34/56
EX-2.1
from 425 128 pages Agreement and Plan of Merger Among Biocryst Pharmaceuticals, Inc., Idera Pharmaceuticals, Inc., Nautilus Holdco, Inc., Island Merger Sub, Inc. and Boat Merger Sub, Inc. Dated as of January 21, 2018
12/34/56
EX-2.1
from 8-K 128 pages Agreement and Plan of Merger Among Biocryst Pharmaceuticals, Inc., Idera Pharmaceuticals, Inc., Nautilus Holdco, Inc., Island Merger Sub, Inc. and Boat Merger Sub, Inc. Dated as of January 21, 2018
12/34/56
EX-2.4
from 425 11 pages Side Agreement to Investor Financing Agreement
12/34/56
EX-2.4
from 8-K 11 pages Side Agreement to Investor Financing Agreement
12/34/56
EX-2.3
from 425 27 pages Voting and Post-Closing Lock-Up Agreement
12/34/56
EX-2.3
from 8-K 27 pages Voting and Post-Closing Lock-Up Agreement
12/34/56
EX-2.2
from 8-K 37 pages Investor Financing Agreement by and Among Biocryst Pharmaceuticals, Inc. and the Investors Listed on Schedule 1 Dated as of October 17, 2012
12/34/56
EX-2.2
from 425 37 pages Investor Financing Agreement by and Among Biocryst Pharmaceuticals, Inc. and the Investors Listed on Schedule 1 Dated as of October 17, 2012
12/34/56
EX-2.1
from 8-K 106 pages Merger Agreement by and Among Presidio Pharmaceuticals, Inc., S Sub, Inc., Biocryst Pharmaceuticals, Inc. and Shareholder Representative Services LLC, Solely in Its Capacity as Holder Representative Dated as of October 17, 2012
12/34/56
EX-2.1
from 425 106 pages Merger Agreement by and Among Presidio Pharmaceuticals, Inc., S Sub, Inc., Biocryst Pharmaceuticals, Inc. and Shareholder Representative Services LLC, Solely in Its Capacity as Holder Representative Dated as of October 17, 2012
12/34/56
EX-2
from SC 13D/A 1 page Agreement
12/34/56
EX-2
from SC 13D 1 page Transactions in the Stock by the Reporting Persons During the Past Sixty Days
12/34/56